Previous 10 | Next 10 |
Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire —ARIKAYCE ® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net Product Sales o...
Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire BRIDGEWATER, N.J. , Jan. 2, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious...
2023-12-14 17:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Insmed To Present at the Nasdaq 49th Investor Conference PR Newswire BRIDGEWATER, N.J. , Nov. 29, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare dis...
2023-11-25 16:32:53 ET More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc. Mirum Pharmaceuticals, Inc. (MIRM) Q3 2023 Earnings Call Transcript BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript Immunocore: First Half Of 2024 IMC-F106...
Insmed To Present at Two November Conferences PR Newswire BRIDGEWATER, N.J. , Nov. 8, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today ...
Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the Globe PR Newswire — Company-wide day of service brings more than 700 employees together to volunteer in 25 locations throughout the U.S., Europe , and Japan — BRIDGE...
Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List PR Newswire -- Insmed Leads Science Top Employers List for Third Consecutive Year -- BRIDGEWATER, N.J. , Oct. 26, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global bioph...
2023-10-26 15:02:10 ET Insmed, Inc. (INSM) Q3 2023 Earnings Conference Call October 26, 2023, 08:30 ET Company Participants Bryan Dunn - IR William Lewis - President, CEO & Chairman Sara Bonstein - CFO Conference Call Participants Andrea Tan - Gol...
2023-10-26 07:33:19 ET More on Insmed Insmed's Arikayce: A High Flyer With A Heavy Load Insmed Incorporated (INSM) Q2 2023 Earnings Call Transcript Insmed gains as antibacterial agent hits main goal in Phase 3 trial Seeking Alpha’s Quant Rating on Insm...
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 10:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-09 08:00:06 ET Vamil Divan from Guggenheim issued a price target of $95.00 for INSM on 2024-07-09 06:44:00. The adjusted price target was set to $95.00. At the time of the announcement, INSM was trading at $70.05. The overall price target consensus is at $72.91 w...
Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference PR Newswire —New Graph Depicting 52-Week FEV1 Data Illustrate Significantly Less Decline in Lung Function for Bren...